Growth-regulating cellular genes or genes encoding proteins involved in cell cycle control are likely to be major targets of viral gene products in the establishment of a cellular state favourable for a permissive infection. We have examined whether infection of permissive fibroblasts with human cytomegalovirus (HCMV) results in trans-regulation of such cellular genes. Here we have shown that the proto-oncogenes c-fos and c-myc are specifically induced during immediate early (IE) and early times of HCMV infection, as has recently been shown for the heat shock protein 70 gene (hsp70). Deletion analyses and transfection assays of all three promoters showed that previously defined control sequences upstream of the constitutive promoters and downstream of the mRNA cap site are not required for this up-regulation by HCMV, such that the minimal inducible promoters of c-los, c-myc and the hsp70 gene contained only 50 to 60 bp upstream of the transcription start site. Cotransfection assays with vectors expressing HCMV major IE cDNAs showed that the 72K IEl and 80K IE2 proteins are involved in the up-regulation of these promoters. IE1 and IE2 products independently were able to up-regulate the minimal constitutive promoters of the constructs tested here, but trans-activation by IE1 and IE2 together was synergistic. In the case of the hsp70 promoter, promoter constructs containing a variety of different TATA elements could be activated by the 72K IE1 and 80K IE2 proteins.
Introduction
Infection of permissive fibroblasts with human cytomegalovirus (HCMV) has been shown to stimulate cellular DNA synthesis and cell proliferation (St Jeor et al., 1974) , as well as RNA synthesis (Tanaka et al., 1975) . HCMV is also able to induce transcription specifically from cellular genes like the heat shock protein 70 gene (hsp70) (Santomenna & Colberg-Poley, 1990) . Similarly, recent work on a number of cellular proto-oncogenes has shown increased expression of c-fos, c-myc and c-jun during the initial phase of HCMV infection, apparently as an effect of virus binding (Boldogh et al., 1991) . These results imply that the virus itself might participate in promoting changes in cellular gene expression, perhaps establishing a favourable cellular state for permissive infection.
Upon virus infection, HCMV genes are expressed in a temporally regulated manner and give rise to immediate early (IE), early (E) and late gene products (Wathen & t Present address: CRC/Wellcome Institute, Tennis Court Road, Cambridge CB2 1QR, U.K.
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0001-0972 © 1992 SGM Stinski, 1982) . IE genes are the first to be expressed after HCMV infection and do not require de novo protein synthesis (Wathen & Stinski, 1982) . At this time, the most abundantly transcribed RNAs originate from the major IE region under the control of a strong promoter/ enhancer (MIEP) (Boshart et al., !985) , and differential splicing of at least five exons gives rise to several gene products: IE1 mRNA is about 1-95kb in size and consists of exons 1 to 4 (Stinski et al., 1983) , whereas the IE2 region encodes a family of mRNAs ranging in size from 1.4 to 2-25 kb (Stenberg et al., 1985) and containing sequences from differently spliced exons 1, 2, 3 and 5. Both nuclear phosphoproteins play a key role in controlling later viral gene function. IE2 proteins have been shown to up-regulate heterologous (non-HCMV) (Hermiston et al., 1987) as well as homologous (HCMV) promoters (Malone et al., 1990) , and to down-regulate MIEP . IE1 has been shown to upregulate its own promoter , although until now it has been reported to have little effect on heterologous promoters (Hermiston et al., 1987; . However, murine CMV (MCMV) IE1 has been shown to up-regulate c-fos (Schickendanz et al., 1988) .
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We examined whether expression of HCMV genes plays a role in the activation of genes involved in growth regulation and cell cycle control, and the underlying mechanisms of this trans-activation. We concentrated our studies on the proto-oncogenes c-fos and c-myc, and on the hsp70 gene. c-fos and c-myc expression is usually low in quiescent cells, but is rapidly and heavily induced during the transition from the Go to G t phase. Both c-fos and c-myc have been shown to be part of dimeric DNAbinding complexes and to regulate transcription (Chiu et al., 1988; Blackwood & Eisenman, 1991) . It has been suggested that c-fos and c-myc are important in cellular growth and differentiation, and have been found to be regulated by a large number of diverse factors (for a review see Curran, 1988) .
Here, we present data which show that the 72K IE 1 and 80K IE2 proteins of HCMV are independently able to up-regulate the c-fos, c-myc and hsp70 promoter by acting through constitutive promoter sequences, that co-expression of these IE proteins results in synergistic trans-activation, and that trans-activation from these promoters could be mediated by a variety of TATA elements. Finally, we discuss the implications for possible mechanisms involved in trans-activation by these IE1 and IE2 products. During the course of this work we will refer to the 72K IE1 protein as IE1 and the 80K IE2 protein as IE2.
Methods
Cell culture. Flow 2002, a human embryonic lung fibroblast cell line, and IBR cells, a simian virus 40 (SV40) large T immortalized human skin fibroblast cell line (Mayne et al., 1986) , were maintained as monolayers in Eagle's M E M supplemented with 10 ~ foetal calf serum (FCS). Flow 2002 fibroblasts are fully permissive for HCMV infection, whereas HCMV infection of IBR fibroblasts results in expression of IE gene products, as shown by immunofluorescence microscopy, but limited productive infection (Walker, 1991) . Flow 2002 cells were split 1:3 every 6 days and 1BR cells were split 1:3 every 3 days.
RNA isolation and probing. For RNA isolation, Flow 2002 fibroblasts were maintained in MEM supplemented with 0-5~ FCS i2 h prior to infection. Total cellular RNAs of HCMV-infected cells (AD169 at 3 to 5 p.f.u./cell for 12 h) or mock-infected cells supplemented with the same volume of additional MEM as for virus infection were prepared by lysing cells in 4 M-guanidinium thiocyanate followed by CsC1 gradient centrifugation, phenol/chloroform extraction and ethanol precipitation. RNA was quantified by measuring absorbance at 260 nm. RNA (5 ~tg) was slot blotted onto Hybond-N, prehybridized for 24 h and hybridized with nick-translated [~-32p]CTP-labelled c-fosand c-myc-specific probes for 48 h. After autoradiography, filters were stripped and reprobed with y-actin probe.
Plasmids. pSV2IE1 was made by blunt ending a BamHI fragment of pJDO83 (Akrigg et aL, 1985) containing an HCMV IE1 cDNA and cloning into a blunt-ended EcoRl/BamHl deletion of pSG5 (Green et al., 1988) . pHMI21, a full-length IE2 cDNA in Bluescript (Stratagene) under the control of the SV40 early promoter enhancer, was a kind gift from Dr T. Stamminger (Erlangen, Germany). pSVEneo has been described (Southern & Berg, 1982) . All the inserts in these expression vectors used are under control of the SV40 early promoter, c-fosCAT deletion constructs originated from a mouse c-fos clone (Gilman et al., 1986) and were a kind gift from Dr M. Gilman (Cold Spring Harbor, New York, U.S.A.). c-mycCAT deletion vectors were a generous gift from Dr T. Kouzarides (Wellcome/CRC, Cambridge, U.K.). pc-fos-50/5CAT, pc-fos-33/5CAT and pc-myc-55/15CAT were cloned by amplifying specific fragments by the polymerase chain reaction using oligonucleotide primers, and ligating them into the parent vectors. The hsp70CAT constructs and the expression vector pE1A (Simon et al., 1988) were kindly provided by Dr J. R. Nevins (Howard Hughes Medical Institute, Durham, N.C., U.S.A.). pSV2CAT and pRSVCAT (Gorman et al., 1982) (Gorman et al., 1982) . After autoradiography, spots were excised and quantified by liquid scintillation counting. (lanes 1 to 3), pHPvCAT (lanes 4 to 6), pHCll70CAT (lanes 7 to 9), pSVzCAT (lanes 10 and 11) or pRSVCAT (lanes 12 and 13). Control mock-infected cells (lanes 3, 6, 9, 11 and 13) were supplemented with 1 ml of MEM containing 10~ FCS. Numbers above each lane indicate relative CAT activity. Percentage conversion of [14C]chloramphenicol for lanes 1 to 13 was 43, 1-3, 0.8, 38, 0.9, 0.8, 16, 1-8, 0.3, 18, 7.4, 17 and 7. and 7), whereas mock infection had no effect on the expression of these promoters ( 
Results

HCMV infection increases
Sequence requirements for trans-activation
The upstream sequences of c-fos and hsp70 are well characterized and a number of binding sites for regulatory proteins have been m a p p e d within these promoters. Gene regulation of c-myc also involves upstream regulatory elements and at least two transcription start sites, P-I and P-II (Kelly & Siebenlist, 1986) . P-II is positioned 163 bp downstream of the transcription start site of P-I. Also, c-myc requires regulatory elements within exon I (Bentley & Groudine, 1986) . The c-fos, c-myc and hsp70 constructs which were upregulated by H C M V contain most of these major control sequences (Fig. 2 ). Therefore we examined specifically which of these promoter regions was important for transactivation by H C M V by using 5' and 3' deletion constructs of these three promoters.
Upstream regulatory sequences, such as the serum response element (SRE) and the cyclic A M P response element (CRE), were not required for H C M V transactivation of the c-fos promoter as deletion of these elements did not affect C A T activity (Fig. 4a, lanes 1 to  6) . Deletion mutants pc-fos-80CAT and pc-fos-56CAT carry 109 bp of leader sequences 3' to the transcription start site which could be a target for post-transcriptional regulation, so we constructed pc-fos-50/5CAT, which is deleted of all the leader sequences apart from the cap site. Lane 7 in Fig. 4(a) shows that even this minimal promoter was fully trans-activated by H C M V to levels comparable to the full-length promoter.
A deletion of the c-fos promoter down to position -33 (pc-fos-33/5CAT) is no longer trans-activated by H C M V (Fig. 4a, lanes 9 and 10) . Although this rules out promoter-independent trans-activation by H C M V , it does not necessarily define the region of the c-fos because this promoter deletion construct also showed no basal activity. Consequently, it is possible that this deletion simply results in a non-functional promoter.
Deletion studies on the c-myc promoter showed similar results. A deletion of more than 2 kb 5' to the TATA box appeared to have no effect on trans-activation by HCMV in primary fibroblasts (Fig. 4b, lanes 1 to 4) . Constructs containing either P-I (Fig. 4b , lanes 5 and 6) or P-II (Fig.  4b , lanes 9 and 10) with approximately 100 bp of additional flanking sequence were both up-regulated. Interestingly, vectors containing P-I appeared to be trans-activated more strongly than vectors containing P-II. This could be explained by differences in basal level activities of P-I and P-II which could not be detected in primary fibroblasts. However, we carried out the same experiments in a transformed fibroblast cell line (1BR) which increased basal activity of P-I-and P-II-based vectors considerably and allowed a direct comparison of the relative levels of trans-activation. Fig. 4 (b) confirms that P-I (lanes 11 and 12) was up-regulated to a higher level by HCMV than P-II (lanes 13 and 14) . Also, further deletions 5' and 3' to P-I, leaving just 55 bp upstream of the transcription start site and 15 bp downstream, were trans-activated to a similar level as the full-length promoter (Fig. 4b, lanes 7 and 8) . As for c-fos, these results emphasize the importance of basal promoter sequences of c-myc in HCMV trans-activation.
That the hsp70 gene is trans-activated by HCMV infection is well established (Santomenna & ColbergPoley, 1990 ), but the mechanism is not known. Fig. 4(c) shows that a deletion of more than 1 kb of the hsp70 gene promoter, leaving just 77 bp 5' to the transcription start site, was still trans-activated by HCMV (lanes 1 to 4). Even a further deletion, leaving just 44 bp of upstream sequences (lanes 5 to 8) had no major effect on the ability of HCMV to trans-activate the hsp70 promoter in primary fibroblasts. These results show that basal promoter sequences of the hsp70 gene are sufficient for trans-activation by HCMV.
IE gene products are sufficient for trans-activating the c-fos, c-myc and hsp70 promoters
In the experiments we have described so far, HCMV infection was routinely for 10 h. The IE gene products of HCMV are the most abundantly expressed at this time, although some E gene products will also be found. Therefore, we examined whether HCMV IE genes were specifically involved in the up-regulation of c-fos, c-myc and hsp70 promoters and, if so, whether sequence requirements for IE trans-activation would be similar to those for HCMV trans-activation of c-fos, c-myc and hsp70 promoters. As the basal levels of the minimal promoters were extremely low in F2002, we performed these experiments in 1BR fibroblasts in which these constructs establish a higher basal level of activity. For these experiments we used two c D N A clones from the major IE transcription unit, pSV2IE1 expressing exons 1, 2, 3 and 4 (encoding the 72K IE1 protein) and pHMI21 expressing exons 1, 2, 3 and 5 (encoding the 80K IE2 protein). Both c D N A s were under the control of the SV40 promoter/enhancer. After transfection of the two expression vectors into fibroblasts, we were able to show by immunofluorescence microscopy both expression and nuclear localization of IE1 and IE2 using the MAb 1-D64, which recognizes epitopes common to both IE1 and IE2 (Walker, 1991) . Fig. 5(a) shows that these IE gene products were able to up-regulate the c-fos, c-myc and hsp70 promoters. In detail, IE1 and IE2 both moderately trans-activated all three promoters, with IE2 being the stronger trans-activator of the c-fos and c-myc regulatory regions (compare lanes 2 and 3, 6 and 7) and IE1 the stronger trans-activator of the hsp70 promoter (lanes 10 and 11). This latter observation is consistent with recent observations (Colberg-Poley et al., 1992) .
However, in all cases the most extensive up-regulation was seen when cells were cotransfected with IE1 and IE2 (lanes 4, 8 and 12). As the inserts in the IE expression vectors were placed under the control of the strong SV40 early promoter/enhancer, we cotransfected non-specific pSV2neo to control for promoter competition effects; these were not found (Fig. 5a, lanes 1, 5 and 9) . Similarly, an expression vector containing only exon 5 of IE2, similar to pRL51 which does not trans-activate heterologous promoters , also did not transactivate c-fos, c-myc and hsp70 regulatory sequences (data not shown). Also, an expression vector containing an internal deletion within exon 4 of IE1 no longer transactivated these promoters (Walker, 1991; unpublished results) . These controls confirm that the observed transactivation by IE1 and IE2 expression vectors is due to functional IE gene products.
We then examined whether IE1 and IE2 could also up-regulate the minimal HCMV-inducible promoters of c-fos, c-myc and hsp70. As demonstrated in Fig. 5(b) , the trans-activation by IE1 and IE2 of the minimal promoters was similar to that seen with the full-length constructs in Fig. 5 (a) . IE 1 and IE2 both up-regulate all three promoter deletions, with IE2 being the stronger activator of the c-fos and c-myc minimal promoters (compare lanes 2 and 3, 6 and 7) and IE1 showing a higher up-regulation of the hsp70 minimal promoter (lanes 10 and 11). Again, the highest level of transactivation of all three p r o m o t e r -C A T constructs was found after cotransfection of IE1 and IE2 (lanes 4, 8 and 12) . These data suggest that the constitutive promoter of each of the control regions is a potential target sequence for IE1 and IE2 trans-activation. trans-activation is abolished (Simon et al., 1988) .
Consequently, we used a similar approach and transfected CAT vectors with inserts under the control of the hspTO promoter containing its genuine T A T A box (TATAAA) or the SV40 early T A T A box (TATTTAT).
The hspTO promoter was trans-activated by IE1 and IE2
regardless of the origin of the T A T A motif (Fig. 7 , compare lanes 2 and 7, 3 and 8). However, we have also shown recently that constructs containing a substitution of the hsp70 promoter T A T A element or the T A T A element of the human immunodeficiency virus (HIV) L T R with a mutant T A T A motif are no longer transactivated by IE2, ruling out promoter-independent effects of this trans-activator .
We also included the E1A trans-activating protein as a control in this experiment. As expected, E1A trans- H C M V up-regulation of the c-myc promoter reveals another interesting aspect. In normal cells 8 0~ of the c-myc transcripts are initiated from P-II, whereas P-I is used more frequently in B cell abnormalities (see Kelly & Siebenlist, 1986 for review). The basal level of P-II transcripts in mock-infected cells is higher than that of P-I, but the latter is more strongly up-regulated during H C M V infection. A similar promoter switch has also been shown to occur upon BRLF1 (an IE gene of Epstein-Barr virus) trans-activation of the c-myc promoter (Gutsch et al., 1990) . Further studies to define the exact transcription start site for c-myc in HCMVinfected and non-infected cells are in progress. Cotransfection experiments using IE 1 and IE2 expression vectors with c-fos, c-myc and hsp70 promoter-CAT constructs have shown that the IE proteins of HCMV are, at least in part, responsible for the observed HCMVmediated trans-activation. IE1 (exons 1 to 4) independently up-regulated all three promoters. Until recently, little or no effect of IE 1 on heterologous promoters has been described (Hermiston et al., 1987; . However, more recently in an independent study IE1 has been shown to up-regulate the hsp70 promoter (Colberg-Poley et al., 1992) as well as the HIV LTR (Biegalke & Gebaelle, 1991 ; Ghazal et al., 1991 ; Walker et al., 1992) . In addition, MCMV IE1 has also been shown to up-regulate c-fos expression in mouse fibroblasts (Schikendanz et al., 1988) .
IE2 also trans-activates all three cellular promoters, and trans-activates c-myc and c-fos to an even higher level than does IE1. This is consistent with data showing IE2 to be a moderately strong trans-activator of heterologous promoters (Hermiston et al., 1987; .
Our results show that independent IE1 or IE2 transactivation, as well as IE1/IE2 synergistic trans-activation, of the c-myc, c-fos or hsp70 promoters requires only minimal promoter sequences. Similarly, we and others (Biegalke & Gebaelle, 1991; Walker et al., 1992) have been able to demonstrate that IE1 trans-activation of the HIV LTR also depends only on basal HIV promoter sequences. These results contrast with the observed sequence requirements for positive autoregulation of the MIE enhancer by IE1, in which the 18 bp repeat motif of the MIE enhancer (Sambucetti et al., 1989) has been shown to serve as the IEl-responsive element. There are little available data defining which promoter sequences are necessary for the well established IE2 transactivation of heterologous promoters. have strongly trans-activated pA10CAT, a minimal SV40 CAT reporter construct which contains only 72bp upstream of the transcription start site, whereas the full-length SV40 promoter is only weakly trans-activated by IE2.
Several investigators have pointed out that when examining IE1 and IE2 trans-activation maximal upregulation of the target genes is usually produced when IE1 and IE2 are cotransfected, even if IE1 does not upregulate the target promoter itself (Hermiston et al., 1987; Stenberg et al., 1990) . Although our data do show trans-activation of c-los, c-myc and hsp70 by IE 1 and IE2 independently, maximal up-regulation is always produced by cotransfection. Also, the effect of IE 1 and IE2 together is synergistic, as has been observed by others (Hermiston et al., 1987; Stenberg et al., 1990) . This synergistic effect of IE1 and IE2 is found with the minimal inducible promoters of c-fos, c-myc and hsp70. Also, consistent with the data of Biegalke & Geballe (1991) and in contrast to those of Ghazal et al. (1991) , we have observed synergistic trans-activation by IE1 and IE2 of a minimal promoter (-46/-8) of the HIV LTR (Walker, 1991) .
Mutational analyses of the hsp70 gene TATA box have shown that up-regulation by IE1 and IE2 does not depend on a specific TATA box motif. This is different from E1A trans-activation of the hsp70 promoter containing the TATA mutation. Recently it has been demonstrated that E1A is dependent on the specific TATAA sequence motif in the hsp70 promoter for upregulation; an hsp70 promoter containing the SV40 TATA box is not upregulated (Simon et al., 1988) . These results indicate that, although IE1 and IE2, like E1A, appear to act through constitutive promoter sequences to up-regulate the hsp70 promoter, the mechanisms involved are not identical. However, in this context it is interesting to note that a cloned 20 kbp DNA fragment of HCMV containing the major IE gene region can functionally complement an adenovirus mutant (dl312) defective in the E1A viral gene product (Spector & Tevethia, 1986) .
We believe that HCMV IE1 and IE2 can act in a manner similar to a number of other IE proteins of dsDNA viruses, including pseudorabies virus (PrV) and herpes simplex virus (HSV) which promiscuously transactivate early viral as well as cellular promoters. The HSV ICP4 protein has been shown to bind DNA specifically (Freeman & Powell, 1982) and to be able to trans-activate a thymidine kinase promoter containing a TATA sequence only (Imbalzano et al., 1991) . The IE gene product of PrV has been shown to bind directly to DNA sequences around the TATA motif (Cromlish et al., 1989) and to facilitate TFIID interaction with the TATA box during nucleosome assembly (Abmayr et aL, 1988) . In this case an acidic activation domain of PrV IE has recently been implicated in trans-activation (Martin et al., 1990) .
Recently, Pizzorno et al. (1991) have mapped two trans-activating domains within IE2. These domains can independently trans-activate transcription from a GAL4 DNA-binding site-bearing promoter when fused to the DNA-binding domain of the yeast trans-activator GAL4. Both these regions are also acidic in character, and the N-terminal domain is encoded by exon 3 of the major IE transcription unit and therefore is also present in IE1. In addition, it seems noteworthy that the HCMV IE1 protein has a highly acidic C terminus, and a ChouFasman computer analysis has predicted an a-helical structure for this region (C. Hagemeier, unpublished results) . Consequently, work in progress is aimed at detecting any direct or indirect interaction between IE1 and IE2 and DNA sequences of the minimal inducible promoters and analysing the HCMV IE1 protein for domains important for trans-activation.
